Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,656 | 137,361 | 63,024 | 55,860 | 120,176 |
| Marketable Securities | 219,978 | 277,630 | 372,191 | 435,049 | 377,656 |
| Receivables | 32,479 | 29,792 | 28,745 | 26,862 | 26,168 |
| TOTAL | $383,445 | $470,769 | $490,457 | $540,127 | $545,370 |
| Non-Current Assets | |||||
| PPE Net | 822 | 906 | 899 | 987 | 1,276 |
| Other Non-Current Assets | 8,895 | 12,960 | 12,729 | 12,597 | 12,758 |
| TOTAL | $9,717 | $13,866 | $13,628 | $13,584 | $14,034 |
| Total Assets | $393,162 | $484,635 | $504,085 | $553,711 | $559,404 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 109,808 | 109,688 | 109,569 | 109,452 |
| Accounts payable and accrued liabilities | 89,494 | 73,682 | 95,185 | 116,977 | 109,888 |
| TOTAL | $90,845 | $187,022 | $207,117 | $230,077 | $221,584 |
| Non-Current Liabilities | |||||
| Long Term Debt | 223,856 | 223,603 | 223,352 | 223,104 | 222,856 |
| Other Non-Current Liabilities | 6,616 | 6,464 | 6,431 | 7,453 | 7,288 |
| TOTAL | $230,472 | $230,067 | $229,783 | $230,557 | $230,144 |
| Total Liabilities | $321,317 | $417,089 | $436,900 | $460,634 | $451,728 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,826 | 41,783 | 41,687 | 41,670 | 41,417 |
| Common Shares | 42 | 42 | 42 | 42 | 41 |
| Retained earnings | -2,177,675 | -2,174,885 | -2,169,023 | -2,136,888 | -2,116,063 |
| Other shareholders' equity | -7,203 | -7,619 | -7,623 | -8,256 | -7,969 |
| TOTAL | $71,845 | $67,546 | $67,185 | $93,077 | $107,676 |
| Total Liabilities And Equity | $393,162 | $484,635 | $504,085 | $553,711 | $559,404 |